Aravive, Inc. (ARAV) Social Stream



Aravive, Inc. (ARAV): $0.04

0.01 (-13.39%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add ARAV to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#144 of 393

in industry

ARAVIVE INC (ARAV) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ARAV.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 5 $26 $18 $22 $0.114 19198.25%
2022-03-03 5 $26 $14 $19.333 $0.114 16858.77%
2022-05-13 4 $26 $9 $17.666 $0.114 15396.49%
2022-05-27 4 $26 $6 $16.666 $0.114 14519.3%
2022-10-11 5 $26 $6 $16.25 $0.114 14154.39%
2022-10-27 5 $18 $6 $10.25 $0.114 8891.23%
2022-11-10 4 $18 $6 $10.25 $0.114 8891.23%
2023-01-05 2 $10 $10 $10 $0.114 8671.93%
2023-02-21 4 $18 $7 $11.666 $0.114 10133.33%
2023-03-16 4 $18 $10 $13.333 $0.114 11595.61%
2023-06-05 5 $18 $10 $13 $0.114 11303.51%
2023-07-10 5 $18 $9 $12.333 $0.114 10718.42%
2023-08-22 5 $10 $0.25 $6.416 $0.114 5528.07%
NA 1 $NA $NA $NA $0.114 NA%

The Trend in the Analyst Price Target


ARAV's average price target has moved down $16.08 over the prior 27 months.

Over the past 26 weeks, ARAV's average upside potential has been 1,619.89%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-21 4 18 7.00 11.666 1.800 548.11%
2023-03-16 5 18 10.00 13.333 1.830 628.58%
2023-08-22 5 10 0.25 6.416 0.157 3986.62%
2023-08-22 4 10 0.25 5.125 0.157 3164.33%
2023-08-22 4 10 0.25 6.416 0.157 3986.62%

ARAV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 5 0 0 5

The Trend in the Broker Recommendations


ARAV's average broker recommendation rating worsened by 2 over the prior 43 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ARAVIVE INC's upside potential (average analyst target price relative to current price) is higher than 2097.86% of all US stocks.
  • ARAVIVE INC's number of analysts covering the stock is higher than 353.93% of all US stocks.
  • In terms of how ARAVIVE INC fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -1392.84% of that group.
  • ARAVIVE INC's average analyst price target is higher than 484.25% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ARAVIVE INC are ARCT, AVDL, and ABUS.

What is the outlook for ARAV? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!